INFORMATION FOR
Copy Link
Dear Alumni,
Yale University recently announced the introduction of Alumni Affiliate status for former residents and fellows of Yale School of Medicine (YSM). This milestone has been met with great enthusiasm by our community.
The Section of Rheumatology, Allergy & Immunology is excited to further engage with former trainees by keeping you informed about the latest research, patient care initiatives, and notable successes of our faculty, trainees, and alumni. As such, we hope you will share your personal and professional updates with us.
Our section continues to thrive, and we have recently welcomed several new faculty members, each bringing unique strengths that will enhance our clinical, research, and educational missions. In addition, I am pleased to share that we have selected three new fellows for our Rheumatology fellowship and two new fellows for our Allergy & Immunology fellowship beginning this fall. We look forward to welcoming them to our team!
I hope you enjoy reading about some of the other news and initiatives happening across the section. If you have other news to share about your work, please reach out to us.
Sincerely,
Rick Bucala, MD, PhD
Chief, Section of Rheumatology, Allergy & Immunology
Waldemar Von Zedtwitz Professor of Medicine (Rheumatology) and professor of Pathology, Yale School of Medicine, and of Epidemiology (microbial diseases), Yale School of Public Health
Copy Link
Despite advances in treatment for rheumatoid arthritis, joint erosion persists even during disease remission. A new Yale study explains the cellular underpinnings of this ongoing joint destruction.
In modern medicine, antibiotics are among the most powerful tools for preventing and treating life-threatening bacterial infections. Their effectiveness, however, often depends on using the right drug at the right time.
A new study finds ammonia production in the gut drives a reduced appetite for protein when recovering from acute illness.
A new study tested an innovative online screening questionnaire to help identify people who may have axial spondyloarthritis and guide them to the right care more quickly.
Scientists discovered an unusual method of antibody production in the gut that may help future vaccine design. They reported their findings in Immunity.
A study in the Journal of Clinical Investigation finds promise in pairing a drug that blocks a distinct immunosuppressive arm of the immune response with an established therapy that boosts the immune system to fight cancer.
Copy Link
